Edition:
United Kingdom

Pernix Therapeutics Holdings Inc (PTX.OQ)

PTX.OQ on NASDAQ Stock Exchange Global Market

1.60USD
13 Aug 2018
Change (% chg)

$-0.05 (-3.03%)
Prev Close
$1.65
Open
$1.70
Day's High
$1.70
Day's Low
$1.58
Volume
20,839
Avg. Vol
9,628
52-wk High
$3.35
52-wk Low
$1.20

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 28.14 -1.566
FY 2017 Dec '17 41.54 -2.797
Sep '17 40.47 0.385
Jun '17 34.32 -2.158
Mar '17 29.74 -2.941
FY 2016 Dec '16 30.17 -8.908
Sep '16 41.47 -2.990
Jun '16 36.75 -4.669
Mar '16 32.47 -4.243
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.93 32.76
P/E High - Last 5 Yrs. -- 40.66 45.45
P/E Low - Last 5 Yrs. -- 23.70 24.26
Beta 1.69 0.90 0.89
Price to Sales (TTM) 0.26 3.94 5.75
Price to Book (MRQ) -- 4.88 5.47
Price to Tangible Book (MRQ) -- 5.70 7.04
Price to Cash Flow (TTM) -- 22.85 23.29
% Owned Institutions 21.30 1.23 2.21

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.51
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.35 5.22
Payout Ratio(TTM) -- 45.86 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -6.61 2.27 8.01
Sales (TTM) vs TTM 1 Yr. Ago -17.36 4.77 5.64
Sales - 5 Yr. Growth Rate 18.37 9.94 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 53.78 17.61 20.61
EPS (TTM) vs TTM 1 Yr. Ago 29.25 -- --
EPS - 5 Yr. Growth Rate -- 9.75 10.66
Capital Spending - 5 Yr. Growth Rate 41.15 15.37 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.67 2.15 2.22
Current Ratio (MRQ) 0.75 2.94 3.03
LT Debt to Equity (MRQ) -- 10.03 12.51
Total Debt to Equity (MRQ) -- 14.07 16.85
Interest Coverage (TTM) -9.29 35.78 32.63

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 70.21 54.72 54.37
Gross Margin - 5 Yr. Avg. 64.57 52.10 52.17
EBITD Margin (TTM) 4.02 -- --
EBITD - 5 Yr. Avg -0.57 18.48 10.65
Operating Margin (TTM) -93.55 14.31 4.33
Operating Margin - 5 Yr. Avg. -56.18 14.43 6.06
Pre-Tax Margin (TTM) -120.18 14.80 5.18
Pre-Tax Margin - 5 Yr. Avg. -69.72 14.82 6.49
Net Profit Margin (TTM) -120.56 11.05 1.48
Net Profit Margin - 5 Yr. Avg. -65.04 11.13 2.77
Effective Tax Rate (TTM) -- 23.22 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.49 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 733,508 953,061,589 860,433,555
Net Income/Employee (TTM) -884,286 112,127,232 101,214,060
Receivable Turnover (TTM) 2.90 5.72 5.87
Inventory Turnover (TTM) 4.45 2.63 3.41
Asset Turnover (TTM) 0.42 0.96 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -50.40 11.58 11.13
Return on Assets - 5 Yr. Avg. -23.23 12.95 12.40
Return on Investment (TTM) -74.47 15.07 14.61
Return on Investment - 5 Yr. Avg. -31.36 16.90 16.13
Return on Equity (TTM) -- 16.60 16.33
Return on Equity - 5 Yr. Avg. -138.91 17.97 17.39
  1 Year 3 Year 5 Year
Sales % -19.90 18.40 18.37
EPS (TTM) % 22.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pernix Therapeutics Holdings Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 29.56%
# of Holders: 43
Total Shares Held: 3,509,494
3 Mo. Net Change: 1,242,166
# New Positions: 2
# Closed Positions: 1
# Increased Positions: 6
# Reduced Positions: 3
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.